Literature DB >> 2509064

Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition.

P O Mulder1, J G Bouman, J A Gietema, H Van Rijsbergen, N H Mulder, S Van der Geest, E G De Vries.   

Abstract

Recipients of autologous bone marrow transplantation (ABMT) for pan class="Disease">solid tumors need nutritional supn>port to maintain their body weight (BW). Severe BW-reduction (9.9%) was noticed retrospn>ectively in ten ABMT n>an class="Species">patients fed orally, despite intensive counseling or occasional tube feeding. A prospective, randomized study of hyperalimentation (25 g nitrogen (N) and 3400 nonprotein kilocalories) with total parenteral nutrition (TPN) or partial parenteral plus enteral nutrition by tube feeding (PPN/EN) was done in 22 patients. Nutritional assessment included balance measurements of N, Na, K, Cl, P, Ca, Mg, Cu, and Zn, and serial measurements of BW, serum albumin, prealbumin, and transferrin. Both regimens were effective in maintaining BW (maximum percent of change, 2.5) and N-balance. Blood products accounted for an additional N-intake of 13% in both groups. The TPN group had a higher dietary N-intake versus PPN/EN, a positive K balance but negative Ca, Mg, Cu, and Zn balances. More mineral supplementation was given in the PPN/EN group where positive K, Mg, and Zn balances were seen. Visceral proteins and IgG, IgA, and IgM levels were decreased on days 7, 14, and 21. Creatinine clearance increased significantly in both groups. Compared with TPN, the PPN/EN group showed a twofold number of patients with a positive blood culture, although this observation did not reach statistical significance and patients had fewer days of diarrhea (31.1% versus 54.3%, P less than 0.01). Hyperalimentation with PPN/EN is an acceptable alternative to TPN in the nutritional support of ABMT recipients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509064     DOI: 10.1002/1097-0142(19891115)64:10<2045::aid-cncr2820641013>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Enteral nutrition after bone marrow transplantation.

Authors:  A Papadopoulou; A MacDonald; M D Williams; P J Darbyshire; I W Booth
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

2.  Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer.

Authors:  E G de Vries; S Rodenhuis; H C Schouten; P S Hupperets; W V Dolsma; J V Lebesque; G H Blijham; M Bontenbal; N H Mulder
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Gastrointestinal side effects and adequacy of enteral intake in hematopoietic stem cell transplant patients.

Authors:  Maegan Walrath; Cheryl Bacon; Sharon Foley; Henry C Fung
Journal:  Nutr Clin Pract       Date:  2014-09-16       Impact factor: 3.080

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.